Lipid Digestion and Absorption

Abstract

This unit will cover the digestion and absorption of lipids, and the generation of chylomicrons. Lipid digestion is quite a bit different from the soluble digestion of carbohydrates and lipids, so we will also cover bile acids and their role in absorption. Chapter 15 in Lippincott’s Illustrated Reviews in Biochemistry available in reserve(Ferrier 2017).

Learning Objectives

Key Vocabulary and Concepts

Dietary Lipids and Dietary Intake

The three main dietary lipids we ingest are triglycerides, phospholipids and cholesterol. Of these, on average we consume much more in terms of triglycerides (95g for men, 65g/day for women) than phospholipids (1-2g/day) or cholesterol (300 mg/day). For the average person that’s about 1/3 of their total caloric intake (National Center for Health Statistics 2017). Dietary lipids are also our only source of the essential \(\omega\)3 and \(\omega\)6 fatty acids. Furthermore several lipid soluble vitamins are carried and absorbed along with lipids. These include vitamins A, D, E and K, so impairments in lipid absorption can affect their absorption as well.

Lipid Digestion in the Upper Digestive Tract

There is substantial debate about whether lipids can be tasted, in the way that we have specific receptors in our tongue that can sense sweet, bitter, sour, salt, and umami flavors. While there are fatty acid receptors on the tongue, at this stage most lipids are in the triglyceride form. Rather lipid flavor is thought to be a combination of several fatty acid receptors, along with the mechanical sensation of lipids in the oral cavity (DiPatrizio 2014).

Lipid digestion, relative to carbohydrate digestion is relatively simple from an enzymatic perspective. This process is somewhat complicated by the insoluble nature of fat. Rather than letting food diffuse and break down into aqueous pieces, fat will aggregate in globules and often float as it passes through the digestive tract. Therefore lipid digestion is a combination of enzymatic processing, along with the solubilization needed for absorption.

This enzyme is known as Lingual Lipase and is secreted from glands underneath the tongue. While it is present in the mouth, it is only functional in the low pH environment, such as that in the stomach. Lingual Lipase tends to cleave the sn3 fatty acids from triglycerides. This results in a diacylglycerol and a free fatty acid. Lingual Lipase is especially effective in removing medium chain fatty acids from triglyceride molecules (Jensen, DeJong, and Clark 1983).

This enzyme is secreted from chief cells in the stomach, and like Lingual Lipase is most active in the low pH of the stomach. Gastric Lipase prefers to release fatty acids from the sn1 and sn3 positions of a lipid. For both phospholipids and triglycerides this leaves a monoacylglycerol with the fatty acid still in the sn2 position. The removal of the acyl chain make the lipid much more soluble and easier to emulsify into smaller droplets.

Emulsification is the breaking of lipid droplets in to smaller and smaller particles. A large globule of fat is not going to be able to easily pass through a cellular membrane, so as lipids pass through the digestive tract, both enzymatic digestion and mechanical churning to make the droplets as small as possible.

Absorption and Digestion of Lipids in the Small Intestine

Most lipid digestion and absorption occurs within the small intestine. At this point the semi-digested, emulsified lipid droplets come into contact with bile salts, which further aid in their solubilization into very tiny lipid droplets called micelles. Micelles are generally coated with an amphipathic layer of bile salts, and contain an internal core of fatty acids, and monoacylglycerols.

Bile Salts and Their Regulation

Bile salts are cholesterol-derived compounds that are generated initially in the liver In the liver through a series of enzymatic steps, cholesterol is converted into primary bile acids such as cholic acid and chenodeoxycholic acid. This step is rate-limited by an enzyme known as 7-\(\alpha\)-hydroxylase, which in turn is transcriptionally downregulated when liver primary bile acids are high (Ramirez et al. 1994).

while still in the liver, bile acids have either a glycine or a taurine amino acid group added to them. This yields a conjugated bile acid, of which there are several species. This new bile acid is very amphipathic, with a charged group from the amino acid on one end and the modified cholesterol on the other end. This makes bile acids very effective in interacting with and solubilizing dietary lipids.

, after their lipid cargo has been absorbed with up to 95% of bile salts being reabsorbed via a sodium co-transporter in the terminal illeum. One approach therefore to remove cholesterol from the blood stream is bile acid sequestrants that impair the uptake of bile salts, and thus the release of cholesterol.

Uptake of Lipids in the Small Intestine

After a brief diversion about bile salts and their role in generating lipid micelles lets return to the small intestine where we now have partially hydrolyzed triglycerides and phospholipids. A third Lipase, called Pancreatic Lipase is secreted into the small intestine, it again is specific to the sn1/sn3 positions but compared to Lingual Lipase, has stronger activity towards long chain fatty acids (Jensen, DeJong, and Clark 1983). Pancreatic Lipase activity is dependent on a coenzyme called colipase. It is secreted as a precursor called procolipase, and is activated by trypsin-mediated cleavage. Recall that at this stage many lipids are solubilized within bile-salt containing micelles. The presence of colipase allows Pancreatic Lipase to be active even on lipids contained within the micelles. More details about how colipase can help Pancreatic Lipase function can be found in Van Tilbeurgh et al. (1999).

We have been focusing mainly on triglycerides, but two more enzymes in the small intestine are important for the absorption of phospholipids and cholesterol. For phospholipids, the key enzyme is Pancreatic Phospholipase. This is a class A2 phospholipase. At this stage the phospholipid is known as a lysophospholipid. For cholesterol if the cholesterol is esterified this is removed by an enzyme termed Cholesterol Esterase. Similarly to a lysophospholipid, cholesterol is now in a more amphipathic form allowing for better absorption.

The predominant pathway for cholesterol uptake is via a steroid transporter called NPC1L1(Altmann et al. 2004; Iqbal and Hussain 2005). Plant sterols, which look very similar to cholesterol are imported along with cholesterol, but then are specifically exported back into the gut lumen via ATP-dependent transporters ABCG5/8. Cholesterol uptake is reduced when enterocyte cholesterol levels are high. For example, bile acid synthesis deficiency results in a dramatic decrease in cholesterol absorption to balance the limited release (Repa et al. 2000; Wang 2007). The mechanism for this is via a transcription factor called SREBP2. Normally SREBP2 increases the levels of NPC1L1. When cholesterol levels are high, SREBP2 is inhibited, and cholesterol uptake is reduced (see Figure [fig:srebp2]. The upshot of this is that when endogenous cholesterol levels are high, dietary cholesterol absorption is reduced. This is likely one reason why dietary cholesterol intake does not strongly modulate blood cholesterol levels.

These lipids are absorbed across the apical membrane of enterocytes. The precise mechanism seems to be a combination of passive transport and passive diffusion of micelles within the membranes, leaving the bile salts in the gut lumen. Remember that both micelles and phospholipid membranes are very amphipathic, so one theory is that the lipid containing micelles just passively pass through the membrane. Another thought is that they are bound to surface receptors then endocytosed. Either way, the majority of lipids are taken out of the gut lumen into the microvilli in the small intestine.

Short Chain Fatty Acid Absorption

Both short and medium chain fatty acids are more or less soluble in water and therefore do not require micelles for transport into the enterocytes. These fatty acids are thought to be passively absorbed in the small intestine after digestion.

On the other hand, short chain fatty acids are more rare in our diet than long chain fatty acids. If ingested directly these can be absorbed by enterocytes, but most SCFA’s are generated by our microbiome in the large intestine. These bacteria use undigested fiber and unabsorbed proteins and peptides as fuel. The major products of these reactions are SCFA (Cummings et al. 1987). Colon epithelial cells can take up these metabolites, and use these SCFA as a fuel source, preferring butyrate. Acetate and propionate to enter the circulation and enter the circulation. While this may seem like a minor event, SCFA’s provide about 10% of our total caloric requirements and are a major way by which the gut microbiome can affect our energy balance. For more details about SCFA and bacterial physiology refer to a recent review by (Koh2016?).

Endocrine Control of Lipid Digestion and Absorption

We have mentioned several pancreatic and biliary secretions that aid in digestion of lipids. The major regulators are cholecystokinin and secretin. CCK is released from the lower duodenum and acts at several places including the gallbladder and pancreas. In the gallbladder, CCK promotes contraction of the gallbladder, and relaxation of a sphincter connecting the bile duct to the duodenum. This results in excretion of bile salts into the small intestine. As we have discussed previously CCK, is activated by the parasympathetic nervous system and inhibited by the sympathetic nervous system. At the same time, CCK promotes the release of sodium bicarbonate and Pancreatic Lipase and colipase from the pancreas. This process is also aided by secretin which also promotes pancreatic juice release.

Transport of Lipids out of the Enterocytes

Lipids are absborbed as free cholesterol, monoacylglycerol, lysophospholipids and free fatty acids into the enterocyte. Each of these can be quite toxic to the cell, so they are very rapidly reconverted into storage forms (esterified cholesterol and triglycerides). This re-esterification is critically important for absorption and eventual transport to other tissues.

This is the first lipoprotein complex we will discuss. These particles vary in size from quite large (like chylomicrons) to very small and dense The surface of the chylomicrons contains phospholipids, free cholesterol and specific amphipathic proteins called apolipoproteins. In the case of chylomicrons, these protein are Apolipoproteins A1 and B48. The chylomicrons are secreted from the enterocytes into the lacteals of the lymphatic system. They then bypass the portal vein at first and travel to peripheral sites for rapid utilization in tissues such as adipose and muscle. Once in circulation, chylomicrons pick up Apolipoproteins CII and E. As we will describe in the lipid transport lecture these allow for the chylomicrons to recognize and activate Lipoprotein Lipase for final delivery of fatty acids and cholesterol to peripheral tissues.

are secreted directly into the bloodstream. These more soluble fatty acids are directly transported via the portal vein to the liver. This is one of the reasons why gallbladder and chylomicron-generating diseases can be treated with medium chain fatty acids, and why medium chain fatty acids are rapidly converted into ketones.

Altmann, Scott W., Harry R Davis, Li-Ji Zhu, Xiaorui Yao, Lizbeth M Hoos, Glen Tetzloff, Sai Prasad N Iyer, et al. 2004. “Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption.” Science (New York, N.Y.) 303 (5661): 1201–4. https://doi.org/10.1126/science.1093131.
Cummings, J. H., E W Pomare, W J Branch, C P Naylor, and G T Macfarlane. 1987. “Short Chain Fatty Acids in Human Large Intestine, Portal, Hepatic and Venous Blood.” Gut 28 (10): 1221–27. https://doi.org/10.1136/gut.28.10.1221.
DiPatrizio, Nicholas V. 2014. “Is Fat Taste Ready for Primetime?” Physiology and Behavior 136: 145–54. https://doi.org/10.1016/j.physbeh.2014.03.002.
Ferrier, Denise. 2017. Lippincott Illustrated Reviews: Biochemistry. 1496344499: LWW.
Iqbal, Jahangir, and M Mahmood Hussain. 2005. “Evidence for Multiple Complementary Pathways for Efficient Cholesterol Absorption in Mice.” Journal of Lipid Research 46 (7): 1491–501. https://doi.org/10.1194/jlr.M500023-JLR200.
Jensen, Robert G., Felice A. DeJong, and Richard M. Clark. 1983. “Determination of Lipase Specificity.” Lipids 18 (3): 239–52. https://doi.org/10.1007/BF02534556.
National Center for Health Statistics. 2017. Health, United States, 2016: With Chartbook on Long-term Trends in Health.” Center for Disease Control, 314–17.
Ramirez, M I, D Karaoglu, D Haro, C Barillas, R Bashirzadeh, and Gregorio Gil. 1994. “Cholesterol and Bile Acids Regulate Cholesterol 7 Alpha-Hydroxylase Expression at the Transcriptional Level in Culture and in Transgenic Mice.” Molecular and Cellular Biology 14 (4): 2809–21. https://doi.org/10.1128/MCB.14.4.2809.Updated.
Repa, Joyce J., Erik G. Lund, Jay D. Horton, Eran Leitersdorf, David W. Russell, John M. Dietschy, and Stephen D. Turley. 2000. “Disruption of the Sterol 27-Hydroxylase Gene in Mice Results in Hepatomegaly and Hypertriglyceridemia.” Journal of Biological Chemistry 275 (50): 39685–92. https://doi.org/10.1074/jbc.M007653200.
Van Tilbeurgh, H., S. Bezzine, C. Cambillau, R. Verger, and F. Carrière. 1999. “Colipase: Structure and Interaction with Pancreatic Lipase.” Biochimica Et Biophysica Acta - Molecular and Cell Biology of Lipids 1441 (2-3): 173–84. https://doi.org/10.1016/S1388-1981(99)00149-3.
Wang, David Q.-H. 2007. “Regulation of Intestinal Cholesterol Absorption.” Annual Review of Physiology 69 (1): 221–48. https://doi.org/10.1146/annurev.physiol.69.031905.160725.